Dr. Brad William Desilva, MD

Dr. Desilva practices at Havener Eye Institute Op Care 340B & Osu Eye Physicians and Surgeons LLC - HOPD in Dublin, Ohio.

Dr. Desilva's NPI, 1467494401, was assigned on June 12, 2006. Dr. Desilva graduated from Ohio State College of Medicine in 2003. Dr. Desilva holds Ohio license 35087448.

Dr. Desilva's primary practice is Havener Eye Institute Op Care 340B & Osu Eye Physicians and Surgeons LLC - HOPD, at 6700 University Blvd, Dublin, OH 43016.

Dr. Desilva's primary practice is Havener Eye Institute Op Care 340B & Osu Eye Physicians and Surgeons LLC - HOPD in Dublin, Ohio. Dr. Desilva is also affiliated with Ohio State University Hospital. The medical group on file is OSU Otolaryngology Head & Neck Surgery. Dmand AI also links Dr. Desilva to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Desilva's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desilva practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Desilva's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Desilva is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Desilva is licensed in Ohio.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear and thyroid surgery among the conditions Dr. Desilva treats.

CMS data shows 1,138 Medicare services from Dr. Desilva across 11 procedure codes in 2024, for 560 Medicare patients. Medicare paid $82,966 for them.

CMS counts 560 Medicare patients who saw Dr. Desilva in 2024. The largest group is 65 to 74, with 281 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Desilva's median patient age at 59, with 59% women.

In 2024, Dr. Desilva wrote 747 Medicare Part D claims for 249 patients. 96% of them were for generic drugs. CMS names the drug for 622 of them, across 17 drugs with 11 or more claims each, at $7,122 in total drug cost. In 2023, CMS named 493 claims across 13 drugs.

Dr. Desilva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Desilva as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Desilva, published from 2012 to 2023. 2018 was the busiest year, with 6. The most frequent topics are Laryngoscopy, Vocal Cord Dysfunction and Laryngeal Diseases. Dr. Desilva has published most often in Laryngoscope. Dr. Desilva's most frequent co-authors are Laura A. Matrka, MD, Ryan John Ivancic, MD and David Zachariah Allen.

CMS Open Payments shows 2 general payments to Dr. Desilva from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $87.

Dmand AI lists 1 award for Dr. Desilva, most recently CMS Stage 1 EHR in 2013.

Dr. Desilva graduated from Ohio State College of Medicine in 2003.

Dr. Desilva is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.